Phreesia, Inc. Reaffirms Earnings Guidance for the Full Fiscal Year Ending January 31, 2024 and Fiscal Year 2025
September 06, 2023 at 04:03 pm
Share
Phreesia, Inc. reaffirmed earnings guidance for the full fiscal year ending January 31, 2024 and fiscal year 2025. The company is maintaining its revenue outlook for the full fiscal year ending January 31, 2024 at between $353 million and $356 million, implying year-over-year growth of 26% to 27%.
The company is maintaining its $500 million revenue target to be achieved by annualizing highest-revenue quarter in fiscal year 2025 and the company continues to expect to reach profitability during fiscal year 2025.
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. The Company also provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
PHREESIA, INC. 
